Adoption of the HPV vaccine: a case study of three emerging countries

The human papillomavirus (HPV) vaccine has recently attracted considerable attention in emerging countries, due to its potential to reduce the impact of HPV-related diseases. This case study sheds new light about the variety of HTA arrangements, methods and processes involved in the adoption and use...

Full description

Saved in:
Bibliographic Details
Published in:Journal of comparative effectiveness research Vol. 6; no. 3; p. 195
Main Authors: Caro Martínez, Araceli, Espín Balbino, Jaime, Lemgruber, Alexandre, Martín Ruiz, Eva, Olry de Labry Lima, Antonio, García-Mochón, Leticia, Lessa, Fernanda
Format: Journal Article
Language:English
Published: England 01-05-2017
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The human papillomavirus (HPV) vaccine has recently attracted considerable attention in emerging countries, due to its potential to reduce the impact of HPV-related diseases. This case study sheds new light about the variety of HTA arrangements, methods and processes involved in the adoption and use of HPV vaccines in a selected sample of central, eastern and southern Europe and Latin America and the Caribbean, all of them emerging in the use of HTA. A multi-country case study was designed. Mixed methods, document review, semi-structured surveys and personal communication with experts, were used for data collection and triangulation. This study shows that common elements of good practice exist in the processes and methods used, with all countries arriving at the same appraisal recommendations. However, the influence of socio-politico-economic factors appears to be determinant on the final decisions and restrictions to access made. This case study intends to draw useful lessons for policymakers in emerging settings interested in the adoption of the HPV vaccine supported by evidence-informed processes, such as those offered by institutionalized HTA. Future studies are also recommended to elucidate the specific roles that social values and uncertainties play in vaccine decision-making across different societies.
AbstractList The human papillomavirus (HPV) vaccine has recently attracted considerable attention in emerging countries, due to its potential to reduce the impact of HPV-related diseases. This case study sheds new light about the variety of HTA arrangements, methods and processes involved in the adoption and use of HPV vaccines in a selected sample of central, eastern and southern Europe and Latin America and the Caribbean, all of them emerging in the use of HTA. A multi-country case study was designed. Mixed methods, document review, semi-structured surveys and personal communication with experts, were used for data collection and triangulation. This study shows that common elements of good practice exist in the processes and methods used, with all countries arriving at the same appraisal recommendations. However, the influence of socio-politico-economic factors appears to be determinant on the final decisions and restrictions to access made. This case study intends to draw useful lessons for policymakers in emerging settings interested in the adoption of the HPV vaccine supported by evidence-informed processes, such as those offered by institutionalized HTA. Future studies are also recommended to elucidate the specific roles that social values and uncertainties play in vaccine decision-making across different societies.
Author Martín Ruiz, Eva
Olry de Labry Lima, Antonio
Lemgruber, Alexandre
Caro Martínez, Araceli
García-Mochón, Leticia
Espín Balbino, Jaime
Lessa, Fernanda
Author_xml – sequence: 1
  givenname: Araceli
  surname: Caro Martínez
  fullname: Caro Martínez, Araceli
  organization: Andalusian School of Public Health/Escuela Andaluza de Salud Pública (EASP), Granada, Spain
– sequence: 2
  givenname: Jaime
  surname: Espín Balbino
  fullname: Espín Balbino, Jaime
  organization: Instituto de Investigación Biosanitariaibs, Granada, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain
– sequence: 3
  givenname: Alexandre
  surname: Lemgruber
  fullname: Lemgruber, Alexandre
  organization: Pan American Health Organization (PAHO)/Organización Panamericana de la Salud (OPS) Washington, DC 20037, USA
– sequence: 4
  givenname: Eva
  surname: Martín Ruiz
  fullname: Martín Ruiz, Eva
  organization: Andalusian School of Public Health/Escuela Andaluza de Salud Pública (EASP), Granada, Spain
– sequence: 5
  givenname: Antonio
  surname: Olry de Labry Lima
  fullname: Olry de Labry Lima, Antonio
  organization: Instituto de Investigación Biosanitariaibs, Granada, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain
– sequence: 6
  givenname: Leticia
  surname: García-Mochón
  fullname: García-Mochón, Leticia
  organization: Instituto de Investigación Biosanitariaibs, Granada, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain
– sequence: 7
  givenname: Fernanda
  surname: Lessa
  fullname: Lessa, Fernanda
  organization: Pan American Health Organization (PAHO)/Organización Panamericana de la Salud (OPS) Washington, DC 20037, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28485691$$D View this record in MEDLINE/PubMed
BookMark eNo1j01LAzEURYMottYu3Ur-QDSfLxl3pVQrFHShbksmeVNHbGZIZoT-ewvVu7mLczlwr8h56hISciP4nZTC3gfMTHIBjHMrzshUci0ZKKEmZF7KFz8GnK6MvCQT6bQzUIkpWS1i1w9tl2jX0OET6fr1g_74ENqED9TT4AvSMozxcBpkRIp7zLs27WjoxjTkFss1uWj8d8H5X8_I--Pqbblmm5en5-Viw3rB3cA0aG0CqNpGboOPAMAbq-pYoeGIYNF420RxBKp2XgRXe-PAowhKclRqRm5P3n6s9xi3fW73Ph-2_3_UL7OSTLg
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.2217/cer-2016-0071
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2042-6313
ExternalDocumentID 28485691
Genre Journal Article
GroupedDBID 4.4
53G
70G
7X7
8FI
8FJ
AAWTO
ABUWG
ADBBV
AENEX
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BENPR
BPHCQ
BVXVI
CCPQU
CGR
CUY
CVF
ECM
EIF
EJD
FYUFA
GROUPED_DOAJ
H13
HMCUK
HZ~
IAO
IHR
ITC
NPM
NTCAX
O9-
OVD
PQQKQ
PROAC
RFM
RPM
TEORI
UKHRP
ID FETCH-LOGICAL-p108t-46445c63b7d07cad6660f73bd9e50ee67e5a7fd1d663b8a1c8ba586ae1c320e33
IngestDate Sat Sep 28 08:50:04 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords emerging countries
health technology assessment
vaccines
cervical cancer
case study
HPV
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p108t-46445c63b7d07cad6660f73bd9e50ee67e5a7fd1d663b8a1c8ba586ae1c320e33
PMID 28485691
ParticipantIDs pubmed_primary_28485691
PublicationCentury 2000
PublicationDate 2017-May
PublicationDateYYYYMMDD 2017-05-01
PublicationDate_xml – month: 05
  year: 2017
  text: 2017-May
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of comparative effectiveness research
PublicationTitleAlternate J Comp Eff Res
PublicationYear 2017
SSID ssj0000684952
Score 2.088767
Snippet The human papillomavirus (HPV) vaccine has recently attracted considerable attention in emerging countries, due to its potential to reduce the impact of...
SourceID pubmed
SourceType Index Database
StartPage 195
SubjectTerms Brazil
Caribbean Region
Colombia
Developing Countries
Europe
Humans
Latin America
Papillomavirus Infections - prevention & control
Papillomavirus Vaccines - therapeutic use
Poland
Title Adoption of the HPV vaccine: a case study of three emerging countries
URI https://www.ncbi.nlm.nih.gov/pubmed/28485691
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NS-QwFA-jXvayKH7s6io5eBuqTdM26d5GHZmDiPiFN0nSVxlwOqUz3b9_X5q2UwVBD15KSUJC8359H8n7IORYiEylMsk8jdq8FzIJnkbSe5qnYaYSjT-ZNRQnd-L6SV6Mw_Fg0JbZWrV9K6WxDWltI2e_QO1uUmzAd6Q5PpHq-PwU3UfpvGi1QKtUTm4eh_-UsffnLrDZoNxyWWXdkBJgaKOEX1z4bZXbEluLD5RW00sW7lxBWm7ZZA3qTpetJ4mNBFrWV_EXuTupHpXKwOu00-MXRdM9PFOvaKS7eyA1nXV4u4LZS1nppui2C8fpO-x2Cwxvq2m9BhoH_bMMlI-d5-AJ1DwvsNFCMXfhqS2Djns45D1my1x5zvdCIAjqzFEGSgQGiz2rRfXH4WYXs5r6KJplFCdsJQs7D8W2a41sBMjCeO8cyMl4iZZl4JK22gVP3yxnU0w3E7wzV2q15X6T_GxIR0cOKFtkAPk2GbcgofOMIkgogoQ2IPlLFbUQoTVE3ACECG0hQjuI7JCHy_H9-cRr6ml4BfPl0gtR941MzLVIfWFUiparnwmu0wQiHyAWECmRpQw7uJaKGalVJGMFzPDAB853yXo-z-EXoUZw_PW5DbeTOGmUmDhEXdgoyThAYn6TPffVz4VLmvLc7sf-hz0H5McKE3_I-rKs4JCsLdLqqN78_6KcVfs
link.rule.ids 315,782,786,27933,27934
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adoption+of+the+HPV+vaccine%3A+a+case+study+of+three+emerging+countries&rft.jtitle=Journal+of+comparative+effectiveness+research&rft.au=Caro+Mart%C3%ADnez%2C+Araceli&rft.au=Esp%C3%ADn+Balbino%2C+Jaime&rft.au=Lemgruber%2C+Alexandre&rft.au=Mart%C3%ADn+Ruiz%2C+Eva&rft.date=2017-05-01&rft.eissn=2042-6313&rft.volume=6&rft.issue=3&rft.spage=195&rft_id=info:doi/10.2217%2Fcer-2016-0071&rft_id=info%3Apmid%2F28485691&rft.externalDocID=28485691